273 related articles for article (PubMed ID: 15381071)
1. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase.
Lemarteleur T; Gomez D; Paterski R; Mandine E; Mailliet P; Riou JF
Biochem Biophys Res Commun; 2004 Oct; 323(3):802-8. PubMed ID: 15381071
[TBL] [Abstract][Full Text] [Related]
2. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
[TBL] [Abstract][Full Text] [Related]
3. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
Gomez D; Mergny JL; Riou JF
Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
[TBL] [Abstract][Full Text] [Related]
4. Affinity and selectivity of G4 ligands measured by FRET.
De Cian A; Guittat L; Shin-ya K; Riou JF; Mergny JL
Nucleic Acids Symp Ser (Oxf); 2005; (49):235-6. PubMed ID: 17150720
[TBL] [Abstract][Full Text] [Related]
5. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.
Siddiqui-Jain A; Grand CL; Bearss DJ; Hurley LH
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11593-8. PubMed ID: 12195017
[TBL] [Abstract][Full Text] [Related]
6. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence-based melting assays for studying quadruplex ligands.
De Cian A; Guittat L; Kaiser M; Saccà B; Amrane S; Bourdoncle A; Alberti P; Teulade-Fichou MP; Lacroix L; Mergny JL
Methods; 2007 Jun; 42(2):183-95. PubMed ID: 17472900
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase.
Zhou JL; Lu YJ; Ou TM; Zhou JM; Huang ZS; Zhu XF; Du CJ; Bu XZ; Ma L; Gu LQ; Li YM; Chan AS
J Med Chem; 2005 Nov; 48(23):7315-21. PubMed ID: 16279791
[TBL] [Abstract][Full Text] [Related]
9. Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.
Hurley LH; Von Hoff DD; Siddiqui-Jain A; Yang D
Semin Oncol; 2006 Aug; 33(4):498-512. PubMed ID: 16890804
[TBL] [Abstract][Full Text] [Related]
10. Quadruplex-coupled kinetics distinguishes ligand binding between G4 DNA motifs.
Halder K; Chowdhury S
Biochemistry; 2007 Dec; 46(51):14762-70. PubMed ID: 18052204
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
Wang P; Leung CH; Ma DL; Yan SC; Che CM
Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
[TBL] [Abstract][Full Text] [Related]
12. A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
Brassart B; Gomez D; De Cian A; Paterski R; Montagnac A; Qui KH; Temime-Smaali N; Trentesaux C; Mergny JL; Gueritte F; Riou JF
Mol Pharmacol; 2007 Sep; 72(3):631-40. PubMed ID: 17586599
[TBL] [Abstract][Full Text] [Related]
13. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
Yin F; Liu J; Deng X; Wang J
J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
[TBL] [Abstract][Full Text] [Related]
14. Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure.
Rezler EM; Seenisamy J; Bashyam S; Kim MY; White E; Wilson WD; Hurley LH
J Am Chem Soc; 2005 Jul; 127(26):9439-47. PubMed ID: 15984871
[TBL] [Abstract][Full Text] [Related]
15. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
16. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
[TBL] [Abstract][Full Text] [Related]
17. Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis.
Rosu F; De Pauw E; Guittat L; Alberti P; Lacroix L; Mailliet P; Riou JF; Mergny JL
Biochemistry; 2003 Sep; 42(35):10361-71. PubMed ID: 12950163
[TBL] [Abstract][Full Text] [Related]
18. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
19. Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition.
Bhattacharya S; Chaudhuri P; Jain AK; Paul A
Bioconjug Chem; 2010 Jul; 21(7):1148-59. PubMed ID: 20536245
[TBL] [Abstract][Full Text] [Related]
20. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA.
Zhang WJ; Ou TM; Lu YJ; Huang YY; Wu WB; Huang ZS; Zhou JL; Wong KY; Gu LQ
Bioorg Med Chem; 2007 Aug; 15(16):5493-501. PubMed ID: 17574421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
